Diabetes Core Update cover image

Diabetes Core Update – February 2023

Diabetes Core Update

00:00

Concomitant Use of Sulfonyaureus and Beta Blockers in Type 2 Diabetes

Concomitant use of sulfonyaureus and beta blockers was associated with a 50% increased risk of severe hypoglycemia. In the arena of heart failure where there's a lot of medicines in that category, probably the much easier choice is omitting the sulfonya area. And yes, they are cheaper and more available for a lot of patients.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app